Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients-Reference-Cited by-同舟云学术

Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients

Published:2020-11-16 Issue:12 Volume:50 Page:1998-2012
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Oja Anna E.¹,Saris Anno²³,Ghandour Cherien A.¹,Kragten Natasja A.M.¹,Hogema Boris M.⁴,Nossent Esther J.³⁵,Heunks Leo M.A.³⁶,Cuvalay Susan⁷,Slot Ed⁸,Linty Federica⁹,Swaneveld Francis H.⁷,Vrielink Hans⁷,Vidarsson Gestur⁹,Rispens Theo¹⁰^ORCID,Schoot Ellen⁹,Lier René A.W.¹,Ten Brinke Anja¹⁰,Hombrink Pleun¹^ORCID

Affiliation:

1. Department of Hematopoiesis Sanquin Research and Landsteiner Laboratory Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

2. Centre for Experimental and Molecular Medicine Amsterdam UMC Amsterdam The Netherlands

3. Amsterdam UMC COVID Study Group Amsterdam UMC Amsterdam The Netherlands

4. Sanquin Diagnostic Services and Sanquin Research Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

5. Department of Pulmonary Medicine Amsterdam UMC Amsterdam The Netherlands

6. Department of Intensive Care Medicine Amsterdam UMC Amsterdam The Netherlands

7. Unit of Transfusion Medicine Sanquin Blood Supply Amsterdam The Netherlands

8. Laboratory of Blood‐borne Infections Sanquin Blood Supply Amsterdam The Netherlands

9. Department of Experimental Immunohematology Sanquin Research and Landsteiner Laboratory Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

10. Department of Immunopathology Sanquin Research and Landsteiner Laboratory Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202048908

Reference61 articles.

1. An interactive web-based dashboard to track COVID-19 in real time

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. The trinity of COVID-19: immunity, inflammation and intervention

4. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

5. Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Role of Inflammation in Coronavirus Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-10

2. CD4 ⁺ and CD8 ⁺ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment;Science Advances;2024-08-23

3. A novel metric-based approach of scoring early host immune response from oro-nasopharyngeal swabs predicts COVID-19 outcome;Scientific Reports;2024-08-22

4. Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China;BMC Infectious Diseases;2024-08-09

5. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination;iScience;2024-08